Get started
Author

Alem Gusinac

Observed names: Gusinac, A., Gusinac, Alem
ORCID: 0009-0006-1896-4176
Observed ORCID: 0009-0006-1896-4176
OpenAlex ID: A5118863941
Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer
2021 · Andrea Sacchetti, Miriam Teeuwssen, et al. · eLife · 66
Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al. · Clinical Cancer Research · 6
Impact of neoadjuvant chemotherapy on local breast microbiota and macrophages in ER-positive breast cancer with links to treatment response
2026 · Sabine Dieleman, Carlijn Bruggeling, et al. · npj Breast Cancer · 1
PDF
OmicFlow: Fast and Efficient (Automated) Analysis of Sparse Omics Data
2025 · Alem Gusinac, Thomas Ederveen, et al. · 1
PDF
Gut microbiota alterations in individuals with mitochondrial disease caused by the m.3243A >G mutation
2026 · Dave G.J. de Bruijn, Alem Gusinac, et al. · Molecular Genetics and Metabolism
The Mitochondrial Disease Gut Microbiota study & MIDLOC study
2026 · Bruijn, D.G.J., Gusinac, A., et al.
metaBIOMx: Metagenomics pipeline for Microbial shot-gun sequencing data
2026 · Gusinac, Alem, Ederveen, Thomas, et al. · WorkflowHub
metaTAXONx: metataxonomics pipeline for 16S marker-gene sequencing data
2026 · Gusinac, Alem, Ederveen, Thomas, et al. · WorkflowHub
Gut microbiota dysbiosis in people with mitochondrial disease caused by the m.3243A>G mutation
2026 · Dave G.J. de Bruijn, Alem Gusinac, et al. · SSRN Electronic Journal
Supplementary Table 2 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
Supplementary Table 4 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
Supplementary Figure 3 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
PDF
Supplementary Figure 2 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
PDF
Supplementary Figure 4 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
PDF
Supplementary Table 6 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
Supplementary Figure 1 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
PDF
Supplementary Table 5 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
Supplementary Table 1 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
Supplementary Table 3 from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
Data from Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses
2025 · Stefan G. van Ravensteijn, Jacco J. de Haan, et al.
Blood, sweat, and beers: investigating mosquito biting preferences amidst noise and intoxication in a cross-sectional cohort study at a large music festival
2025 · Sara Lynn Blanken, Maartje R. Inklaar, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Author response: Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer
2021 · Andrea Sacchetti, Miriam Teeuwssen, et al.
Works count: 26
Citation count: 74
H-index: 2
I10-index: 1
Year
Topic
Type